| Nov 12 |
Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 11 |
Azenta Q4 2024 Earnings Preview
|
| Nov 4 |
Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast
|
| Nov 4 |
Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value
|
| Oct 30 |
Azenta gets US approval for long-read WGS test
|
| Oct 30 |
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test
|
| Sep 11 |
Azenta: Life Science Play Is Not Coming To Life
|
| Sep 4 |
Azenta appoints John Marotta as CEO
|
| Sep 4 |
AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO
|
